Helomics Holding Corporation, predicted to generate approximately $3.2 million in revenues by the end of 2018 MINNEAPOLIS, Aug. 14, 2018 (GLOBE NEWSWIRE) — Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today financial results for the three and six months ended June 30, 2018 and provided a business update. Highlights of the second quarter of 2018 and recent weeks include: Signed a definitive merger agreement with HelomicsRead more
- Medical Marijuana, Inc. Subsidiaries Kannaway®, HempMeds® and Dixie Botanicals Receive U.S. Hemp Authority Certification Seal
- Midwest Energy Emissions Corp. Secures Multi-Year Contract Renewal of $1M per Year
- INVO BIOSCIENCE LAUNCHES EMBRYOLOGY CENTER IN THE BAY AREA TO SUPPORT DEDICATED INVOCELL CLINIC BEING DEVELOPED BY DR. AIMEE, THE “EGG WHISPERER”
- Vertically integrated cannabis firm Ascend Wellness raises $55 million for expansion
- Lifeline Biotechnologies Updates Shareholders and The Public
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More